Menopause can affect glucose regulation, but hormone changes are only part of the picture. Sleep, activity, muscle mass, medicines and existing diabetes risk also matter. If your readings or symptoms have changed, start with a clinical assessment rather than assuming low oestrogen explains them or that you need a glucose sensor.
Use this checklist to prepare for a health review. It is a prompt for discussion, not a way to diagnose menopause or diabetes.
Oestrogen has effects beyond the reproductive system, including effects on tissues involved in using and storing energy. During the menopause transition, changing hormone levels can coincide with changes in insulin sensitivity. Insulin is the hormone that helps glucose move from the blood into cells.
That relationship is complex. A person can develop insulin resistance before menopause, and not everyone develops high glucose afterwards. Ageing, genetics, illness and medicines can influence the same measurements. Our insulin resistance guide explains why a broader assessment matters.
The ZOE PREDICT study by Bermingham and colleagues found differences in fasting and after-meal metabolism between menopausal groups. Some associations remained in age-matched comparisons. This was observational research, so it cannot prove that menopause alone caused the differences or that everyone should use CGM.
The Australasian Menopause Society explains that midlife weight gain is strongly associated with ageing and lifestyle, while hormonal changes can influence where fat is stored. More abdominal fat can be relevant to metabolic risk, but a change in clothing size does not diagnose insulin resistance.
Sleep disruption, caring responsibilities, pain and reduced opportunity to exercise can also change daily routines. These are practical barriers worth discussing, rather than evidence that your body has stopped responding to healthy habits. A useful plan should fit your circumstances and support adequate nutrition.
Avoid judging progress only by weight or a glucose graph. Strength, blood pressure, laboratory results and the ability to maintain daily activities may provide useful information too. Your clinician can help choose measures that are relevant without making every part of life a monitoring task.

A higher glucose reading can reflect food, illness, stress, medicines or impaired glucose regulation. Menopause does not make an abnormal result unimportant. Persistent thirst, frequent urination, unexplained weight loss or repeated unusual readings should prompt medical assessment, even if you also have familiar menopause symptoms.
Sweating, disturbed sleep, palpitations and feeling shaky are not specific to low glucose. Hot flushes and anxiety can overlap with these experiences. A sensor reading alone cannot establish the cause, especially if it does not match how you feel. Follow your device's confirmation instructions and seek advice about recurrent symptoms.
Some people in perimenopause notice they feel shaky, irritable or light-headed when they go a long time without eating, or a few hours after a large meal. A drop in glucose after eating is called reactive hypoglycaemia, but low glucose is only one possible cause of these feelings. Our guide to reactive hypoglycaemia explains how it is checked. See your GP if episodes keep happening, if you have ever fainted or become confused, or if you take medicines that lower glucose.
If you have diabetes, use your agreed plan for high or low glucose. Do not change doses or add vigorous exercise in response to an unfamiliar reading without following that plan. Severe confusion, collapse, difficulty breathing or marked illness needs urgent medical help. A lifestyle experiment is not an appropriate response to an emergency.
A fasting glucose test measures glucose at one point after the requested fasting period. An HbA1c test reflects glucose exposure over a longer period. Neither test directly measures menopause hormones, and the choice depends on the clinical question and your history. Hormone levels are checked separately, for example with the Menopause Hormone Test. Our perimenopause blood test guide explains which markers are used during the transition.
HbA1c can be affected by conditions that change red blood cells, so your clinician may choose another approach when it is unreliable. The HbA1c calculator converts between reporting units; it does not diagnose diabetes. Some people need an oral glucose tolerance test or repeat testing for clarification.
Discuss blood pressure and lipids as well as glucose (our guide to cholesterol after menopause explains the lipid side). Past gestational diabetes, PCOS, family history and previous abnormal results can influence the assessment. There is no need to wait until symptoms become severe: glucose problems can be present without obvious symptoms, and a GP can advise on appropriate screening.
Start with meals you can repeat comfortably. Include vegetables, a suitable protein source and carbohydrate foods that provide fibre, such as legumes or wholegrains. These foods contribute nutrients beyond their effect on glucose. Cutting out entire food groups because of a sensor rise can make adequate eating harder.
Our soluble fibre guide explains how fibre can affect digestion and why gradual changes may be easier to tolerate. A practical meal might combine beans, vegetables and a grain you enjoy. Adjust it for appetite, cultural preferences, budget and any existing dietary advice.
Water can replace a sugary drink when that suits your routine, but a glucose trace should not decide whether you are allowed to eat. The glucose information hub explains normal food responses and measurement limits. Seek dietitian support if food choices become increasingly restrictive or confusing.
Regular movement supports metabolic health and physical function. Include activities you enjoy and, where appropriate, strength work that helps maintain muscle. The starting point may be gentle walking, adapted exercise or supervised rehabilitation, depending on pain, fitness and other health conditions.
Avoid using exercise to compensate for a meal or chase every glucose rise. For people using diabetes medicines, activity may require a personalised plan to reduce the risk of low glucose. Discuss changes with your treating team, especially if your usual response has become less predictable.
Night sweats and poor sleep can make meals, activity and concentration harder to manage. Raise persistent sleep problems with your GP rather than assuming better glucose control will fix them. Assessment may include menopause symptoms and other causes of disrupted sleep. Improving comfort and daily function is worthwhile in its own right.

Menopausal hormone therapy can affect metabolic measures, and research has reported effects on diabetes risk. However, those findings do not establish it as a treatment to start simply because a CGM graph has changed. Glucose is only one consideration in assessing potential benefits and risks.
The Australasian Menopause Society's guidance describes individual assessment for hormone therapy. Your symptoms, medical history, existing conditions and preferences are relevant to that conversation. If you already use it, tell your clinician about changing glucose patterns; do not adjust or stop treatment based on this article.
A CGM measures glucose in fluid under the skin. It can add information about daily patterns, but it does not measure oestrogen, diagnose menopause or prove why a symptom occurred. It also cannot show that a food change has corrected a hormone imbalance.
If you choose to monitor, agree on a specific question and record relevant context. Compare similar meals on different days rather than treating a single peak as a verdict. Our CGM guide for women distinguishes the evidence for diabetes care from developing uses in other settings.
The Baseline Health Check combines blood markers with a practitioner review to help put results in context. Vively's CGM program provides a different view of everyday glucose patterns. Neither replaces assessment and treatment of menopause symptoms by your GP or relevant specialist.
Explore the Vively CGM program and consider whether it answers a useful question for you.
The menopause transition can be associated with changes in glucose regulation, but it is not the only possible explanation for a high result. Ageing, medicines, illness and existing diabetes risk can also matter. Repeated high readings or symptoms need clinical assessment rather than being dismissed as a normal hormonal change.
No. Hormones can influence insulin sensitivity, but an oestrogen result or menopause diagnosis cannot establish insulin resistance by itself. A clinician considers your history, risk factors and appropriate tests. Avoid assuming that weight changes or a single glucose rise reveal a particular hormone problem or its cause.
Night sweats have several possible causes, including menopause symptoms. They do not by themselves prove low glucose. If you use medicines that can cause hypoglycaemia, follow your monitoring and treatment plan. Recurrent or unexplained symptoms deserve assessment, particularly when they are new or accompanied by other signs of illness.
Hormone therapy can influence metabolic measures, but an individual response cannot be promised. Its suitability depends on a broader assessment of symptoms, medical history and potential benefits and risks. Discuss glucose concerns with your prescriber rather than starting, stopping or adjusting treatment to make a sensor graph flatter.
No blanket carbohydrate exclusion is needed because of menopause. Fibre-rich carbohydrate foods can contribute to a nourishing diet, and the amount that suits you depends on your needs and clinical advice. A dietitian can help adapt meals, particularly if you have diabetes, digestive symptoms or concerns about restrictive eating.
START YOUR BASELINE
Vively includes a Baseline Health Check with 70+ biomarkers, a results report and practitioner support in the $99 a month membership. No minimum term.
Explore Baseline Health CheckSubscribe to our newsletter & join a community of 30,000+ Aussies